Surgery Partners Valuation

SGRY Stock  USD 31.43  1.07  3.52%   
At this time, the company appears to be undervalued. Surgery Partners has a current Real Value of $38.95 per share. The regular price of the company is $31.43. Our model measures the value of Surgery Partners from inspecting the company fundamentals such as Operating Margin of 0.15 %, return on equity of 0.0373, and Shares Outstanding of 127.12 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Surgery Partners' valuation include:
Price Book
1.9768
Enterprise Value
7.1 B
Enterprise Value Ebitda
14.9482
Price Sales
1.3359
Forward PE
23.4742
Undervalued
Today
31.43
Please note that Surgery Partners' price fluctuation is very steady at this time. Calculation of the real value of Surgery Partners is based on 3 months time horizon. Increasing Surgery Partners' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Surgery Partners is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgery Stock. However, Surgery Partners' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  31.43 Real  38.95 Target  46.78 Hype  31.49 Naive  31.52
The intrinsic value of Surgery Partners' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Surgery Partners' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
38.95
Real Value
41.94
Upside
Estimating the potential upside or downside of Surgery Partners helps investors to forecast how Surgery stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgery Partners more accurately as focusing exclusively on Surgery Partners' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.160.250.34
Details
Hype
Prediction
LowEstimatedHigh
28.5031.4934.48
Details
Naive
Forecast
LowNext ValueHigh
28.5331.5234.51
Details
13 Analysts
Consensus
LowTarget PriceHigh
42.5746.7851.93
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Surgery Partners' intrinsic value based on its ongoing forecasts of Surgery Partners' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Surgery Partners' closest peers.

Surgery Partners Cash

185.41 Million

Surgery Valuation Trend

Analysing the historical paterns of Surgery Partners' enterprise value and its market capitalization is a good way to estimate and gauge the value of Surgery Partners over time and is usually enough for investors to make rational market timing decisions.

Surgery Revenue by Product

Surgery Partners Total Value Analysis

Surgery Partners is at this time projected to have valuation of 7.07 B with market capitalization of 3.86 B, debt of 3.06 B, and cash on hands of 227.4 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Surgery Partners fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
7.07 B
3.86 B
3.06 B
227.4 M

Surgery Partners Investor Information

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.98. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgery Partners has Price/Earnings To Growth (PEG) ratio of 1.66. The entity recorded a loss per share of 0.26. The firm had not issued any dividends in recent years. Based on the key indicators related to Surgery Partners' liquidity, profitability, solvency, and operating efficiency, Surgery Partners is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Profit Margin0.150.1489
Slightly Up
Slightly volatile
Total Cash From Operating Activities308.5 M293.8 M
Sufficiently Up
Slightly volatile
Operating Income209.5 M408.5 M
Way Down
Slightly volatile

Surgery Partners Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Surgery Partners has an asset utilization ratio of 39.08 percent. This suggests that the Company is making $0.39 for each dollar of assets. An increasing asset utilization means that Surgery Partners is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid

Surgery Partners Ownership Allocation

The majority of Surgery Partners outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Surgery Partners to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Surgery Partners. Please pay attention to any change in the institutional holdings of Surgery Partners as this could imply that something significant has changed or is about to change at the company.

Surgery Partners Profitability Analysis

The company reported the previous year's revenue of 2.74 B. Net Loss for the year was (11.9 M) with profit before overhead, payroll, taxes, and interest of 574.9 M.

About Surgery Partners Valuation

Our relative valuation model uses a comparative analysis of Surgery Partners. We calculate exposure to Surgery Partners's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Surgery Partners's related companies.
Last ReportedProjected for Next Year
Gross Profit529.4 M377.3 M
Pretax Profit Margin 0.05  0.03 
Operating Profit Margin 0.15  0.15 
Gross Profit Margin 0.19  0.30 

Surgery Partners Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding125.6 M
Forward Price Earnings23.4742

Surgery Partners Current Valuation Indicators

Valuation refers to the process of determining the present value of Surgery Partners and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Surgery we look at many different elements of the entity such as Surgery's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Surgery Partners, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Surgery Partners' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Surgery Partners' worth.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.